Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors

References

• Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–3082.
   PubMed Web of Science ®Google Scholar
• Barcellos CRG, Rocha MP, Hayashida SAY, Nery M, Marcondes JAM. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metab 2007;51:601–605.
   PubMedGoogle Scholar
• Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003;24:302–312.
   PubMed Web of Science ®Google Scholar
• Rose PG. Endometrial carcinoma. N Engl J Med 1996;335:640–649.
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774–800.
   PubMed Web of Science ®Google Scholar
• Mattsson LA, Cullberg G, Hamberger L, Samsioe G, Silfverstolpe G. Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril 1984;42:579–584.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papavassiliou AG, Stylianos A, Kandarakis AS, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Mol Endocrinol 2007;18:208–215.
   Google Scholar
• Holte J, Bergh T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 1994;41:463–471.
   PubMed Web of Science ®Google Scholar
• Cibula D, Cífková R, Fanta M, Poledne R, Zivny J, Skibová J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 2000;15:785–789.
   PubMed Web of Science ®Google Scholar
• Legro RS, Blanche P, Krauss RM, Lobo RA. Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors. Fertil Steril 1999;72:990–995.
   PubMed Web of Science ®Google Scholar
• Legro RS, Kunselman MA, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607–613.
   PubMed Web of Science ®Google Scholar
• Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf) 2001;54:447–453.
   PubMed Web of Science ®Google Scholar
• Marcondes JAM, Hayashida SAY, Barcellos CRG, Rocha MP, Maciel GAR, Baracat EC. Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors. Arq Bras Endocrinol Metab 2007;51:972–979.
   Google Scholar
• Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003;18:2289–2293.
   PubMed Web of Science ®Google Scholar
• Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992. pp 377–384.
   Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:37–45.
   Google Scholar
• Ferriman D, Galwey G. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–1447.
   PubMed Web of Science ®Google Scholar
• Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (AdultTreatment Panel III) final report. Circulation 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TB. Epi Info 2000, a database and statistical program for public health professionals for use on Windows 95, 98, NT, and 2000 computers. Atlanta, Georgia, USA: Center for Disease Control and Prevention; 2000.
   Google Scholar
• Wild RA, Painter PC, Coulson PB, Carruth BK, Ranney GB. Lipoprotein lipid concentration and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985;61:946–951.
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Halser B, Demant T. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome. Gynecol Endocrinol 2002;16:45–51.
   PubMed Web of Science ®Google Scholar
• Slowinska-Srzednicka J, Zgliczynski S, Wierzbicki M, Srzednicki M, Stopinska-Gluszak U, Zgliczynski W, Soszyński P, Chotkowska E, Bednarska M, Sadowski Z. The role of hyperinsulinemia in development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991;14:569–575.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Biri A, Bukan N, Karakoc A, Sancak B, Toruner F, Pasaoglu H. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258–263.
   PubMed Web of Science ®Google Scholar
• Conway RS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;37:119–125.
   PubMed Web of Science ®Google Scholar
• Slowińska-Srzednicka J, Zgliczyński S, Wierzbicki M, Srzednicki M, Stopińska-Gluszak U, Zgliczyński W, Soszyński P, Chotkowska E, Bednarska M, Sadowski Z. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991;14:569–575.
   PubMed Web of Science ®Google Scholar
• Raal FJ. Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord 2009;7:83–88.
   PubMed Web of Science ®Google Scholar
• Russel JC, Amy RM, Graham S, Wenzel LM, Dolphin PJ. Effect of castration on hyperlipemic, insulin resistance JCR:LA-corpulent rats. Atheroscleroisis 1993;100:113–122.
   Google Scholar
• Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988;8:737–741.
   PubMedGoogle Scholar
• Heiss G, Tamir L, Davis CE. Lipoprotein-cholesterol distributions in select North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980;61:302–315.
   PubMed Web of Science ®Google Scholar
• Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(Suppl): S11–S20.
   Google Scholar
• Monrad RN, Grunnet LG, Rasmussen EL, Malis C, Vaag A, Poulsen P. Age-dependent nongenetic influences of birth weight and adult body fat on insulin sensitivity in twins. J Clin Endocrinol Metab 2009;94:2394–2399.
   Google Scholar